TRIML1

Chr 4

tripartite motif family like 1

Also known as: RNF209

The protein functions as a probable E3 ubiquitin-protein ligase that plays an important role in early embryonic development, specifically blastocyst development. Mutations in TRIML1 cause autosomal recessive developmental and epileptic encephalopathy with microcephaly, presenting in early infancy with seizures and severe developmental delays. This gene is highly intolerant to loss-of-function variants, indicating that complete loss of protein function is likely incompatible with normal development.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
2
Pubs (1 yr)
109
P/LP submissions
0%
P/LP missense
1.37
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryTRIML1
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
109 unique Pathogenic / Likely Pathogenic· 95 VUS of 235 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.37LOEUF
pLI 0.000
Z-score 0.35
OE 0.91 (0.621.37)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.41Z-score
OE missense 1.07 (0.971.19)
272 obs / 253.8 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.91 (0.621.37)
00.351.4
Missense OE1.07 (0.971.19)
00.61.4
Synonymous OE1.15
01.21.6
LoF obs/exp: 17 / 18.6Missense obs/exp: 272 / 253.8Syn Z: -1.21
DN
0.76top 25%
GOF
0.7126th %ile
LOF
0.1993th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

235 submitted variants in ClinVar

Classification Summary

Pathogenic98
Likely Pathogenic11
VUS95
Likely Benign19
Benign4
Conflicting2
98
Pathogenic
11
Likely Pathogenic
95
VUS
19
Likely Benign
4
Benign
2
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
98
0
98
Likely Pathogenic
0
0
11
0
11
VUS
0
69
26
0
95
Likely Benign
0
2
17
0
19
Benign
0
0
4
0
4
Conflicting
2
Total0711560229

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

TRIML1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 1 results · since 2015Search PubMed ↗
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC